Automation of Solid form Screening Procedures in the Pharmaceutical Industry—How to Avoid the Bottlenecks-Reference-Cited by-同舟云学术

Automation of Solid form Screening Procedures in the Pharmaceutical Industry—How to Avoid the Bottlenecks

Published:2004-01 Issue:1 Volume:10 Page:45-56
ISSN:0889-311X
Container-title:Crystallography Reviews
language:en
Short-container-title:Crystallography Reviews

Author:

Storey Richard,Docherty Robert,Higginson Paul,Dallman Chris,Gilmore Chris,Barr Gordon,Dong Wei

Publisher

Informa UK Limited

Subject

Condensed Matter Physics,General Materials Science,Biochemistry,General Chemistry,Structural Biology

Link

http://www.tandfonline.com/doi/pdf/10.1080/08893110410001664846

Reference22 articles.

1. Almarsson (2003). Orn Application of HT Crystallisation Technology to the Study of Polymorphism of Pharmaceuticals at ACS Prospectives: Polymorphism in Crystals, Fundamentals, Predictions and Industrial Practice, February 23–26.

2. Byrn, S.R., Pfeiffer, R. and Stowell, J.G. (1999).Solid State Chemistry of Drugs, SSCI Inc.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matching ROY crystal structures to high-throughput PXRD;CrystEngComm;2024

2. Continuous synthesis of dolutegravir sodium crystals using liquid-gas heterogeneous microreactor;Chinese Chemical Letters;2023-03

3. A high-throughput system combining microfluidic hydrogel droplets with deep learning for screening the antisolvent-crystallization conditions of active pharmaceutical ingredients;Lab on a Chip;2020

4. Approaches to Solid-Form Screening;Polymorphism in the Pharmaceutical Industry;2018-12-21

5. Solid State and Polymorphism of the Drug Substance in the Context of Quality by Design and ICH Guidelines Q8-Q12;Polymorphism in the Pharmaceutical Industry;2018-12-21